Introduction to Infectious Diseases

Last update: 20.05.2019

The growing worldwide resistance to antibiotics requires much more cautious use of antibiotics when treating acute infectious diseases. What can Anthroposophic Medicine contribute in this situation? What possibilities does it offer that go beyond just focusing on the pathogens, how does it therapeutically guide and support a patient’s inflammatory response, and strengthen the person’s immunological resources, both acutely and preventatively? Which procedures have proven successful? How can Anthroposophic Medicine benefit patients with infectious diseases, whether acute or long-term?

In this section we present some of Anthroposophic Medicine’s multi-professional therapeutic concepts for common infectious diseases in childhood and adulthood.

 Fig. «Sick person at night» of Ernst Ludwig Kirchner. © akg-images

Research news

Mistletoe therapy in addition to standard immunotherapy in patients with non-small-cell lung cancer indicates improved survival rates 
Immunotherapy with PD-1/PD-L1 inhibitors has significantly improved the survival rates of patients with metastatic non-small-cell lung cancer (NSCLC). Results of a real-world data study (RWD) investigating the addition of Viscum album L. (VA) to chemotherapy have shown an association with improved survival in patients with NSCLC - regardless of age, degree of metastasis, performance status, lifestyle or oncological treatment. The mechanisms may include synergistic modulations of the immune response by PD-1/PD-L1 inhibitors and VA. However, the results should be taken with caution due to the observational and non-randomised study design. The study has been published open access in Cancers
https://doi.org/10.3390/cancers16081609.


Further information on Anthroposophic Medicine